Cargando…

Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design

Herein we present, an exhaustive docking analysis considering the case of autotaxin (ATX). HA155, a small molecule inhibitor of ATX, is co-crystallized. In order to further extract conclusions on the nature of the bond formed between the ligands and the amino acid residues of the active site, densit...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsamakas, Sotirios, Papadopoulos, Anastasios G., Hadjipavlou-Litina, Dimitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273881/
https://www.ncbi.nlm.nih.gov/pubmed/27617984
http://dx.doi.org/10.3390/molecules21091185
_version_ 1783377489821696000
author Katsamakas, Sotirios
Papadopoulos, Anastasios G.
Hadjipavlou-Litina, Dimitra
author_facet Katsamakas, Sotirios
Papadopoulos, Anastasios G.
Hadjipavlou-Litina, Dimitra
author_sort Katsamakas, Sotirios
collection PubMed
description Herein we present, an exhaustive docking analysis considering the case of autotaxin (ATX). HA155, a small molecule inhibitor of ATX, is co-crystallized. In order to further extract conclusions on the nature of the bond formed between the ligands and the amino acid residues of the active site, density functional theory (DFT) calculations were undertaken. However, docking does not provide reproducible results when screening boronic acid derivatives and their binding orientations to protein drug targets. Based on natural bond orbital (NBO) calculations, the formed bond between Ser/Thr residues is characterized more accurately as a polar covalent bond instead of a simple nonpolar covalent one. The presented results are acceptable and could be used in screening as an active negative filter for boron compounds. The hydroxyl groups of amino acids are bonded with the inhibitor’s boron atom, converting its hybridization to sp(3).
format Online
Article
Text
id pubmed-6273881
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62738812018-12-28 Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design Katsamakas, Sotirios Papadopoulos, Anastasios G. Hadjipavlou-Litina, Dimitra Molecules Article Herein we present, an exhaustive docking analysis considering the case of autotaxin (ATX). HA155, a small molecule inhibitor of ATX, is co-crystallized. In order to further extract conclusions on the nature of the bond formed between the ligands and the amino acid residues of the active site, density functional theory (DFT) calculations were undertaken. However, docking does not provide reproducible results when screening boronic acid derivatives and their binding orientations to protein drug targets. Based on natural bond orbital (NBO) calculations, the formed bond between Ser/Thr residues is characterized more accurately as a polar covalent bond instead of a simple nonpolar covalent one. The presented results are acceptable and could be used in screening as an active negative filter for boron compounds. The hydroxyl groups of amino acids are bonded with the inhibitor’s boron atom, converting its hybridization to sp(3). MDPI 2016-09-07 /pmc/articles/PMC6273881/ /pubmed/27617984 http://dx.doi.org/10.3390/molecules21091185 Text en © 2016 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Katsamakas, Sotirios
Papadopoulos, Anastasios G.
Hadjipavlou-Litina, Dimitra
Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design
title Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design
title_full Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design
title_fullStr Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design
title_full_unstemmed Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design
title_short Boronic Acid Group: A Cumbersome False Negative Case in the Process of Drug Design
title_sort boronic acid group: a cumbersome false negative case in the process of drug design
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273881/
https://www.ncbi.nlm.nih.gov/pubmed/27617984
http://dx.doi.org/10.3390/molecules21091185
work_keys_str_mv AT katsamakassotirios boronicacidgroupacumbersomefalsenegativecaseintheprocessofdrugdesign
AT papadopoulosanastasiosg boronicacidgroupacumbersomefalsenegativecaseintheprocessofdrugdesign
AT hadjipavloulitinadimitra boronicacidgroupacumbersomefalsenegativecaseintheprocessofdrugdesign